Pacira Pharmaceuticals Names James S. Scibetta as President

Pacira Pharmaceuticals, Inc. PCRX today announced that James S. Scibetta has been appointed president, effective October 20, 2015. In this capacity, Mr. Scibetta will oversee the day-to-day operations and tactical execution of the Company's newly formed Customer and Patient Solutions (CPS) group, comprised of its customer-facing resources. He will also continue to oversee the Pacira Science Center Campus (SCC) activities.   Mr. Scibetta will continue to report to Chief Executive Officer and Chairman Dave Stack, who will maintain oversight of the commercial and corporate strategy. Mr. Stack will also continue to lead the development program for the expanded use of EXPAREL® (bupivacaine liposome injectable suspension) and the DepoFoam® pipeline of products, as well as business operations and performance. "Jim is a proven leader with demonstrated excellence in organizational efficiency to optimize results, and has been instrumental in accelerating the growth of Pacira," said Mr. Stack. "This important evolution of senior management See full press release